The Leaf Post

Job Creator, Problem-Solver, Entrepreneur, and Philanthropist Stephen J. Cloobeck Announces Candidacy for California Governor

Job #1: Make California Affordable, Livable, and Workable for All Announcement Ads: ENGLISH SPANISH LOS ANGELES--(BUSINESS WIRE)--On election day, Stephen J. Cloobeck, dedicated father, community leader, serial entrepreneur and founder and former CEO and Chairman of Diamond Resorts International announced his candidacy for Governor of California 2026 via an unprecedented statewide media blitz including television ads on CNN, CNBC, Fox News, MSNBC, Newsmax, and Univision, as well as...
spot_img

Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting

BERWYN, Pa.--(BUSINESS WIRE)--#pharma--Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder,...

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

Special Meeting to Approve $124.6 Million Investment from BAT at $3.2203/share and Creation of “Jupiter” Strategic Investment PoolTORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX:...

Life Is Chill Expands Line of THC Soft Gels with New Live Resin THC Capsules, A First Of Its Kind for the Arizona Market

The new plant-based soft gel will launch on Friday, January 19, providing Arizona consumers with a unique and innovative capsule option.PAYSON, Ariz.--(BUSINESS WIRE)--Ally Biotech,...

Enveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 Series

Enveric to initiate preclinical development of EB-003 in 2024 in preparation for IND submissionCAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a...

Enveric Biosciences Reports Year End Progress for Preclinical Development of Lead Prodrug Candidate EB-373

The ongoing GLP Safety and Toxicology Program of EB-373 is thus far proceeding on time with favorable resultsCAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric”...

ZYUS Life Sciences Corporation Announces Issuance of Shares for Debt Settlement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO--(BUSINESS WIRE)--ZYUS Life Sciences Corporation (the “Company”) is pleased...

POSaBIT Applies to List Common Shares on the TSXV

TORONTO--(BUSINESS WIRE)--POSaBIT Systems Corporation (CSE: PBIT, OTC: POSAF) (the "Company" or "POSaBIT"), a leading provider of payments infrastructure in the cannabis industry, is pleased...

Protein Ingredients Market Global Outlook & Forecast 2023-2028: Demand for Plant-based Products in Sports Nutrition and Growth in Vegan Population Drives Demand in Protein...

DUBLIN--(BUSINESS WIRE)--The "Protein Ingredients Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global protein ingredients market is expected...

POSaBIT Announces Non-Brokered Unit Offering to Fund Convertible Unsecured Note Maturity

Net impact of 3.2 million fewer shares issued to repay convertible notes and forfeiture of 3.85 million warrantsTORONTO--(BUSINESS WIRE)--POSaBIT Systems Corporation (CSE: PBIT, OTC:...

Enveric Biosciences to Participate in Biotech Showcase 2024 During “J.P. Morgan Week 2024”

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the...

Understanding Consumer Behavior in the Functional Beverages Sector Amidst Post-Pandemic and Inflationary Challenges – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Functional Beverages: Market Trends and Opportunities, 2nd Edition" report has been added to ResearchAndMarkets.com's offering. This new resource presents an in-depth analysis of...

PureTech Year End Update and Outlook for 2024

Strong strategic and clinical progress in 2023, with multiple catalysts expected in 2024 Launching of two new Founded Entities to advance certain programs from the...